tirzepatide vision side effects Ozempic and other weight-loss drugs linked to rare but serious eye conditions Researchers Find Small Increased Risk

Although a majority of oral drugs are absorbed in the small intestine, studies indicate that oral semaglutide is likely absorbed in the stomach

Highlights: GLP-1 receptor drugs cause meaningful and sustained weight loss compared to placebo Industry funding raises concerns over potential bias and long-term safety gaps Independent and equitable access to these medications remains a global priority questions persist about potential biases and long-term impacts

Back Pain: Although rare, back pain has been reported

Prompt consultation can prevent complications and ensure your treatment remains safe and effective

Early-stage clinical trials have produced unprecedented weight-loss results, eclipsing even the massive success of semaglutide ( Ozempic) and tirzepatide ( Mounjaro ), writes Hasina Kathrada for Mail & Guardian

Restarting at your previous dose after such a break could lead to severe gastrointestinal issues